Ophthalmology Diagnostics Market Size & Share 2023 to 2032
Market Size by Product (Optical Coherence Tomography Scanner, Specular Microscopes, Wavefront Aberrometers, Optical Biometry Systems, Corneal Topography Systems), Application, End Use & Forecast.
Report ID: GMI5624
|
Published Date: May 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Ophthalmology Diagnostics Market Size
Ophthalmology Diagnostics Market size was valued at around USD 8.7 billion in 2022 and is projected to grow at 4.4% CAGR from 2023 to 2032 driven by increasing prevalence of ophthalmic diseases.
Ophthalmology Diagnostics Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The benefits associated with eye diagnosis such as reliability in disease screening and reduced severity of disease with a better diagnosis & management are also forecasted to positively impact the industry progress. The ophthalmology diagnostic products are proved to be an ideal instrument to perform eye diagnosis. These diagnostic tests can be employed in diagnostic and treatment decisions for patients in hospital settings comprising prescribing medications in related treatment therapy. Ongoing advancements have favored the evolution of these diagnostic tests that are associated with offering optimum specificity & sensitivity.
This availability of unique and non-invasive diagnostic procedures are allowing ease and accuracy in early diagnosis and control of vision impairment. Reduced time minimized the risk of other infections during testing, and less pain & discomfort will further stimulate the adoption of the product. As World Health Organization (WHO) recognizes eye disease conditions to be of primary importance, various government and non-government bodies are coming forth with awareness programs.
COVID-19 Impact
The recent outbreak of COVID-19 had a negative impact on the ophthalmology diagnostics industry revenue in 2020. The increased demand for COVID-19 treatment had impacted the adoption of ophthalmology diagnostic products and the demand for ophthalmic procedures. 2020 saw the highest incidence and death rates from coronavirus, with people preferring to avoid other treatments in health facilities. The U.S. declared a national emergency and a ban on all elective surgical procedures in outpatient and inpatient settings. The ophthalmologists were at high risk of infection as close contact, droplets, and aerosols during face-to-face clinical examination might facilitate the spread of the SARS-CoV-2 virus.
As a result, the American Academy of Ophthalmology (AAO), the Centers for Disease Control and Prevention (CDC), and the American Society of Retina Specialists among others published clinical recommendations and guidelines for ophthalmology practices. The adoption of these guidelines and fear among patients along with other factors limited the ophthalmology practice during the COVID-19 pandemic. A similar trend was observed in different nations ophthalmology practices, with the majority of ophthalmologists reporting low patient inflow during the lockdown.
Ophthalmology Diagnostics Market Trends
Significant increase in number of patients suffering from ophthalmic diseases such as cataracts, glucoma, vitreoretinal diseases, and refractive errors among others will primarily drive the market growth over the forecast period. According to the World Health Organization latest data, around 1 billion people are suffering from moderate or severe distance vision impairment or blindness attributable to cataract (94 million), refractive error (88.4 million), age-related macular degeneration (8 million), glaucoma (7.7 million), and diabetic retinopathy (3.9 million) among others.
Increasing prevalence of such ailments fuel the demand for ophthalmic devices including ophthalmology diagnostic products. Raising geriatric population suffering from various eye diseases will also significantly drive the market trends. The use of advanced ophthalmology diagnostic product helps to offer efficient diagnosis & treatment, thereby reducing the risk of vision impairment. This rising diseased population is resulting in high adoption of advanced ophthalmology diagnostic devices including fundus cameras, Keratometers, and lensometers among others to enable a doctor to examine the patient eye more effectively with highest precision.
Ophthalmology Diagnostics Market Analysis
The optical coherence tomography scanner segment held the majority of the ophthalmology diagnostics market share in 2022 and was valued at over USD 1.4 billion. This is attributable to the increasing adoption of optical coherence tomography scanner that delivers noninvasive imaging method and uses reflected light to diagnose & manage disorders including glaucoma, diabetes-related retinopathy, etc. These diagnostic products are observed as highly-efficient devices for performing high-resolution cross-sectional imaging. Optical coherence tomography (OCT) scanners are attaining popularity in evaluating optic nerve disorders and different retinal conditions accurately.
The availability of novel OCT devices is providing ease and accuracy in early diagnosis and management of eye ailments that have stimulated the industry revenue. These precise diagnostic procedures are assisting physicians in the decision-making of disease treatment. The recent technological advancements in OCT technology have improved its ability to examine for ophthalmic disorders, contributing to earlier interventions and preservation of vision. Optical coherence tomography imaging along with artificial intelligence is providing multiple benefits in expanding patient screening and facilitating clinical decision-making.
Based on application, the ophthalmology diagnostics market is segmented as cataracts, glucoma, vitreoretinal diseases, refractive errors, surgical assessment, and others. The cataract segment is projected to reach more than USD 6.3 billion by the end of 2032. This owing to the growing prevalence of cataract in an older population and associated blindness & vision impairment. According to the World Health Organizations latest report, cataracts are the major global causes of vision loss and blindness, impacting 94 million people worldwide.
Additionally, the proportion of vision impairment due to cataract is higher in low- & middle-income countries and is expected to affect more individuals in the coming years. Thus, efforts to reduce these ailments social and economic burden have become a major global public health priority. This rising prevalence of cataract is anticipated to play anchoring role in surging the demand for ophthalmology diagnostic services for precise disease management.
Based on end-use, the ophthalmology diagnostics market is segmented as hospitals, ophthalmic clinics, ambulatory surgical centers, and others. The hospitals is likely to cross more than USD 6.2 billion by 2032. The soaring use of novel ophthalmology diagnostic devices in hospital settings delivering rapid and reliable outcomes is estimated to surge the patient preference for these healthcare facilities. The availability of a broad spectrum of diagnostic tests for the eye with proven accuracy is set to drive product preference in hospitals. Growing admissions with eye ailments and growing disease screening initiatives along with the accessibility to board-certified healthcare professionals are some other variables that are augmenting the segment expansion positively.
North America ophthalmology diagnostics market is anticipated to reach USD 5.6 billion by 2032. This is driven by several factors such as the presence of major industry players, an upsurge in the demand for eye disease diagnostic services, rise in the prevalence of vision problems, and growing number of hospital admissions across the country among others. As per the Centers for Disease Control and Prevention(CDC) latest data, around 20 million individuals in the U.S. over 40 years have a cataract in at least one eye and it is expected to reach over 30 million by 2028.
Additionally, glaucoma, a second leading cause of blindness is affecting around 3 million individuals in the U.S. These adverse events are anticipated to upsurge the adoption rate of eye diagnostic testing for better disease management. This is further driving the entry of new players in the market that are projected to increase over the forecast timeframe.
Ophthalmology Diagnostics Market Share
Some of the market players operating in the ophthalmology diagnostics market are
Several strategic initiatives such as novel product launches, strategic collaborations, and geographic expansion to gain competitive advantages are being undertaken. These prominent market players are adopting various organic as well as inorganic growth strategies to obtain competitive advantage and strengthen their market position.
Ophthalmology Diagnostics Industry News:
Ophthalmology diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product, 2018 - 2032 (USD Million)
By Application, 2018 - 2032 (USD Million)
By End-use, 2018 - 2032 (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →